Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders

Journal of Clinical Psychiatry

Volumn 68, Issue SUPPL. 11, 2007, Pages 9-14

  Levin, Frances Rudnick ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; HYPNOTIC SEDATIVE AGENT; METHAMPHETAMINE; NICOTINE; OPIATE;

ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DRUG INTOXICATION; DRUG WITHDRAWAL; FAMILY HISTORY; HUMAN; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOANALYSIS; QUALITY OF LIFE; SUBSTANCE ABUSE; SYMPTOMATOLOGY;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERRORS; HUMAN DEVELOPMENT; HUMANS; REPRODUCIBILITY OF RESULTS; SUBSTANCE-RELATED DISORDERS;

EID: 35348992738     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Barkley RA. Primary symptoms, diagnostic criteria, prevalence, and gender differences. In: Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd ed. New York, NY: Guilford Press; 2006:76-121
2. Barkley RA. ADHD in Adults. In: Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd ed. New York, NY: Guilford Press; 2006:248-296
3. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-723
4. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:1792-1798
5. Mannuzza S, Klein RG, Bessler A, et al. Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993;50:565-576
6. McGough JJ, Smalley SL, McCracken JT, et al. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry 2005;162:1621-1627
7. Wilens TE, Dodson W. A clinical perspective of attention-deficit/ hyperactivity disorder into adulthood. J Clin Psychiatry 2004;65:1301-1313
8. Clure C, Brady KT, Saladin ME, et al. Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. Am J Drug Alcohol Abuse 1999;25:441-448
9. King VL, Brooner RK, Kidorf MS, et al. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis 1999;187:487-495
10. Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend 1998;52:15-25
11. Schubiner H, Tzelepis A, Milberger S, et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry 2000;61:244-251
12. Faraone SV, Biederman J, Spencer TJ, et al. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry 2006;163:1720-1729
13. Mannuzza S, Klein RG. Long-term prognosis in attention-deficit/ hyperactivity disorder. Child Adolesc Psychiatr Clin North Am 2000;9:711-726
14. Carroll KM, Rounsaville BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 1993;34:75-82
15. Wilens TE, Biederman J, Mick E. Does ADHD affect the course of substance abuse? findings from a sample of adults with and without ADHD. Am J Addict 1998;7:156-163
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
17. Weiss M, Hechtman LT, Weiss G. ADHD in Adulthood: A Guide to Current Theory, Diagnosis and Treatment. Baltimore, Md: The Johns Hopkins University Press; 1999
18. Mannuzza S, Klein RG, Addailli KA. Young adult mental status of hyperactive boys and their brothers: a prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1991;30:743-751
19. Barkley RA, Biederman J. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997;36:1204-1210
20. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:885-890
21. Weiss MD, Gadow K, Wasdell MB. Effectiveness outcomes in attention-deficit/hyperactivity disorder. J Clin Psychiatry 2006;67(suppl 8):38-45
22. Corkum P, Tannock R, Moldofsky H. Sleep disturbances in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1998;37:637-646
23. Adler L, Florence M. Scattered Minds: Hope and Help for Adults With ADHD. New York, NY: GP Putnam's Sons; 2006
24. Murphy KR, Gordon M. Assessment of adults with ADHD. In: Barkley RA, ed. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd ed. New York, NY: Guilford Press; 2006:425-450
25. Graham AW, Schultz TK, Mayo-Smith MF, et al, eds. Principles of Addiction Medicine. 3rd ed. Chevy Chase, Md: American Society of Addiction Medicine; 2003
26. Miller NS, Gold MS. Management of withdrawal syndromes and relapse prevention in drug and alcohol dependence. Am Fam Physician 1998;58:139-146
27. DuPaul GJ, Schaughency EA, Weyandt LL, et al. Self-report of ADHD symptoms in university students: cross-gender and cross-national prevalence. J Learn Disabil 2001;34:370-379
28. McCabe SE, Knight JR, Teter CJ, et al. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 2005;100:96-106
29. Teter CJ, McCabe SE, Cranford JA, et al. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J Am Coll Health 2005;53:253-262
30. Kollins SH, Rush CR, Pazzaglia PJ, et al. Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Exp Clin Psychopharmacol 1998;6:367-374
31. Spencer TJ, Biederman J, Ciccone PE, et al. PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am J Psychiatry 2006;163:387-395
32. Bates ME, Bowden SC, Barry D. Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Exp Clin Psychopharmacol 2002;10:193-212
33. Maxwell JC. Emerging research on methamphetamine. Curr Opin Psychiatry 2005;18:235-242
34. Pope GH Jr, Gruber AJ, Hudson JI, et al. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend 2003;69:303-310